#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neoplasm malignant Osteopetrosis Haemophilia B without inhibitors Marginal zone lymphoma Extra-osseous Ewing's sarcoma recurrent Urethral valves Hypoxic-ischaemic encephalopathy Immune thrombocytopenia Leber's congenital amaurosis Transitional cell cancer of the renal pelvis and ureter Phenylketonuria Hereditary ataxia Follicle centre lymphoma follicular grade I II – III refractory Langerhans cell sarcoma Hereditary neuropathic amyloidosis More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Trials in Disease Nodal marginal zone B-cell lymphoma – Treatment Noonan syndrome – Treatment Systemic mastocytosis Hereditary optic atrophy – Life with Disease Prolymphocytic leukaemia – Diagnostics Antisynthetase syndrome – Basic Information Indolent systemic mastocytosis – Trials in Disease Immunodeficiency congenital – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Guanabenz Acetate IMB 101 Rocatinlimab Lamotrigine Tipiracil Golodirsen Varnimcabtagene Autoleucel Oditrasertib Evg321 Hydroxi-Methionine Calcium Milvexian Ivabradine Hydrochloride Doravirine Munc-T3 Ly3298176 MOLNUPIRAVIR Etrumadenant Calcium Carbonate Clioquinol Afm24 More therapies…

    Learn about Your Condition

    Pituitary tumour benign Polymyositis Oropharyngeal cancer recurrent Oropharyngeal cancer Acute coronary syndrome Renal cancer recurrent Head and neck cancer stage III Plasma cell myeloma recurrent Pyoderma Peripheral ischaemia Naevoid melanoma Colorectal cancer stage III Sarcoidosis Haemorrhage intracranial Hypochromic anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study Comparing OXU-001 and Intravitreal Dexamethasone for Patients with Diabetic Macular Edema

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Dexamethasone Acetate Ph. Eur.
    • Dexamethasone
    Hungary Spain

  • Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Retinal vein occlusion
    Investigated Drugs:
    • Aflibercept
    • Fluorescein Sodium
    Austria Bulgaria Czechia Estonia France Germany +8

  • Study on Dexamethasone Eye Drops for Infants with Retinopathy of Prematurity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Retinopathy proliferative
    Investigated Drugs:
    • Dexamethasone Phosphate
    Sweden

  • Study Comparing Bevacizumab and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • Bevacizumab
    Sweden

  • Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

    Not recruiting

    2 1
    Investigated Drugs:
    • Bi 764524
    Germany Hungary Italy Poland Spain

  • Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Avacincaptad Pegol
    • Fluorescein Sodium
    Austria Belgium Croatia Czechia France Germany +4
Previous Page
1 … 33 34 35 36 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!